Global Information
회사소개 | 문의 | 위시리스트

세계 면역측정 시장의 전략, 동향, 예측(2019-2023년)

Immunoassay Markets Strategies and Trends. Forecasts by Instrument Type and by Application and by Country. With Multiplex and Point of Care Market Analysis, Executive Guides and including Customized Forecasting and Analysis. 2019 to 2023

리서치사 Howe Sound Research
발행일 2018년 06월 상품 코드 652164
페이지 정보 영문 221 Pages
가격
US $ 5,995 ₩ 7,096,000 PDF by E-mail (Single User License) help
DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로 1대의 PC에서만 이용할 수 있는 라이선스로 인쇄가 불가능합니다.
US $ 8,995 ₩ 10,648,000 PDF by E-mail (Five User License) help
DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로 5대의 PC에서만 이용할 수 있는 라이선스로 인쇄가 불가능합니다.
US $ 11,995 ₩ 14,199,000 PDF by E-mail (Enterprise License) help
동일기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 편집 및 인쇄는 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계 면역측정 시장의 전략, 동향, 예측(2019-2023년) Immunoassay Markets Strategies and Trends. Forecasts by Instrument Type and by Application and by Country. With Multiplex and Point of Care Market Analysis, Executive Guides and including Customized Forecasting and Analysis. 2019 to 2023
발행일 : 2018년 06월 페이지 정보 : 영문 221 Pages

세계의 면역측정 시장에 대해 조사했으며, 산업 개요, 시장 동향, 최근 발전 동향, 용도·기술별 시장 분석, 향후 전망 및 주요 기업 개요 등을 정리하여 전해드립니다.

제1장 서론·시장 정의

제2장 산업 개요

  • 시장 진출 기업
  • 임상시험기관 시장 부문
  • 면역측정 : 시장·논의
  • 주요 기업의 개요

제3장 시장 동향

  • 성장 촉진요인
  • 성장 억제요인
  • 국가별 면역측정 장비

제4장 면역측정의 최근 발전

제5장 세계 시장

  • 세계 시장 : 국가별

제6장 세계 시장 : 용도별

  • 세계 시장 : 용도별
  • 내분비학
  • 면역
  • 감염증
  • 심장
  • 기타

제7장 면역측정 : 기술별

  • 세계 시장 : 기술별
  • 효소
  • 형광 발광
  • 화학 발광
  • 핵산
  • 신속/POC
  • 방사면역측정(RIA)·기타

제8장 면역측정의 전망

부록

KSA 18.06.22

Table of Tables

  • TABLE 1 MEDICARE CLINICAL LAB EXPENDITURES ACTUAL & FORECAST 2004 TO 2020 ($BILLION)
  • Table 2 Market Players by Type
  • Table 3 Clinical Laboratory Departments and Segments
  • Table 4 Laboratory Management Focus - Different Approaches
  • Table 5 Key Segmentation Variables Going Forward
  • Table 6 The Different Markets for Immunoassay
  • Table 7 The Factors Driving Growth
  • Table 8 Factors Limiting Growth
  • Table 9 - Listing of Current Instrument Specifications
  • Table 10 The Global Immunoassay Market by Country
  • Table 11 Global Market by Application
  • Table 12 Endocrinology Immunoassay by Country
  • Table 13 Immune Immunoassay by Country
  • Table 14 Oncology Immunoassay by Country
  • Table 15 Infectious Disease Immunoassay by Country
  • Table 16 Cardiology Immunoassay by Country
  • Table 17 Other Immunoassay by Country
  • Table 18 Global Market by Technology
  • Table 19 Enzyme Immunoassay by Country
  • Table 20 Flourescence by Country
  • Table 21 Chemiluminesence by Country
  • Table 22 Nucleic Acid by Country
  • Table 23 Rapid/POC by Country
  • Table 24 RIA and Other by Country
  • Table 25 2018 Clinical Lab Fee Schedule

Table of Figures

  • FIGURE 1 MEDICARE CLINICAL LAB EXPENDITURES 2004 TO 2020 ($MILLION)
  • Figure 2 Immunoassay - Key Countries
  • Figure 3 Chart of Growth by Application
  • Figure 4 Chart - Endocrinology Immunoassay by Country
  • Figure 5 Chart - Immune Immunoassay by Country
  • Figure 6 Chart - Oncology Immunoassay by Country
  • Figure 7 Chart - Infectious Disease Immunoassay by Country
  • Figure 8 Chart - Cardiology Immunoassay by Country
  • Figure 9 Chart - Other Immunoassay by Country
  • Figure 10 Chart of Growth by Technology
  • Figure 11 Chart - Technology Change in Planning Period
  • Figure 12 Chart - Enzyme by Country
  • Figure 13 Chart - Flourescence by Country
  • Figure 14 Chart - Chemiluminesence by Country
  • Figure 15 Chart - Nucleic Acid by Country
  • Figure 16 Chart - Rapid/POC by Country
  • Figure 17 Chart - RIA and Other by Country

The workhorse of the diagnostic industry is finding new legs. Advances in genetic knowledge are creating new markets for immunoassay. Rapid diagnostics, point of care, biomarkers and consumer markets are all areas of expansion while traditional immunoassay maintains a strong position in the growing market for clinical diagnostics. We profile 44 companies, large and small, working in this area.

Our research makes you the expert in your organization. Get our research team working for you by ordering all, or a portion, of this comprehensive report. Your credit card order sends the report to your inbox instantly. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to more information. We wrote this report and we are ready, by phone or email, to help you use it. As always, assistance, and additional specific data, is provided without additional charges. All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

Table of Contents

i. Immunoassay Market - Strategic Situation Analysis

ii. Guide for Executives, Marketing, Sales and Business Development Staff

iii. Guide for Management Consultants and Investment Advisors

1. Introduction and Market Definition

  • 1.1 Immunoassay Markets Definition In This Report
    • 1.1.1 Enzyme Based
    • 1.1.2 Immunofluorescence
    • 1.1.3 Chemiluminescence
    • 1.1.4 DNA/NAT
    • 1.1.5 RIA & Other
    • 1.1.6 Reagents/Kits, Analyzers, Software & Services
    • 1.1.7 Infectious Disease
    • 1.1.8 Auto Immune
    • 1.1.9 Endocrinology
    • 1.1.10 Oncology
    • 1.1.11 Cardiology
    • 1.1.12 Other Specialty
  • 1.2 Market Definition
    • 1.2.1 Market Sizes
    • 1.2.2 Currency
    • 1.2.3 Years
  • 1.3 Methodology
    • 1.3.1 Authors
    • 1.3.2 Sources
  • 1.4 U.S. Medical Market and Clinical Laboratory Testing - Perspective
    • 1.4.1 U.S. Medicare Expenditures for Clinical Testing

2. Industry Overview

  • 2.1 Industry Participants
    • 2.1.1 IVD Supplier
    • 2.1.2 Independent lab specialized/esoteric
    • 2.1.3 Independent lab national/regional
    • 2.1.4 Independent lab analytical
    • 2.1.5 Public National/regional lab
    • 2.1.6 Hospital lab
    • 2.1.7 Physician lab
    • 2.1.8 Audit body
  • 2.2 The Clinical Laboratory Market Segments
    • 2.2.1 Traditional Market Segmentation
    • 2.2.2 Laboratory Focus and Segmentation
    • 2.2.3 Hospital Testing Share
    • 2.2.4 Economies of Scale
    • 2.2.4.1 Hospital vs. Central Lab
    • 2.2.5 Physician Office Lab's
    • 2.2.6 Physician's and POCT
  • 2.3 Immunoassay -Markets and Discussion
    • 2.3.1 Instruments - Genetics changes the picture
      • 2.3.1.1 RIA - A Technology Shows its Age
      • 2.3.1.2 Immunoassay vs. PCR vs. Sequencing - A See Saw Battle
      • 2.3.1.3 The Smart Shrinking Instrument - Serious Implications
      • 2.3.1.4 Research Funding and Capital Expense - Instrument Pooling
      • 2.3.1.4 Multiplex vs. POC - A Tradeoff Analysis
    • 2.3.2 Reagents and Kits - Genetics changes the picture
      • 2.3.1.1 Bigger Test Menus a Boon for Kit Market
    • 2.3.3 Physician Office Labs - A New Frontier
    • 2.3.4 Rapid and POCT to Threaten Instrument Markets
    • 2.3.5 OTC and DTC - Huge Market Potential
    • 2.3.6 Economies of Scale. Going Away?
    • 2.3.7 Lower Barriers to Entry for Instruments/Analyzers
    • 2.3.8 Miniturization and Technology Drive Acquisition
  • 2.4 Profiles of Key Companies
    • 2.4.1 Abbott Diagnostics
    • 2.4.2 Abcam
    • 2.4.3 Arlington Scientific
    • 2.4.4 Awareness Technology
    • 2.4.5 Beckman Coulter, Inc
    • 2.4.7 Becton Dickinson
    • 2.4.7 BioCartis
    • 2.4.8 bioMerieux
    • 2.4.9 Bioneer
    • 2.4.10 Bio-Rad Laboratories
    • 2.4.11 Biotek
    • 2.4.12 Boditech Med, Inc
    • 2.4.13 Boster Biological Technology
    • 2.4.14 Diamedix (Erba Diagnostics)
    • 2.4.15 Diasorin S.p.A.
    • 2.4.16 Dynex Technologies
    • 2.4.17 Fujirebio
    • 2.4.18 Gold Standard Diagnostics
    • 2.4.21 Grifols
    • 2.4.22 Hycor Biomedical
    • 2.4.23 Immunodiagnostic Systems (IDS)
    • 2.4.24 Immunodiagnostik AG
    • 2.4.25 Inova Diagnostics
    • 2.4.26 JR Biomedical
    • 2.4.27 Luminex Corp
    • 2.4.28 Meso Scale Discovery
    • 2.4.29 Molecular Devices
    • 2.4.30 MP Biomedical
    • 2.4.31 MyCartis
    • 2.4.32 Ortho Clinical Diagnostics
    • 2.4.33 PerkinElmer
    • 2.4.34 Qiagen
    • 2.4.35 Randox Toxicology
    • 2.4.36 R&D Systems
    • 2.4.37 Roche Molecular Diagnostics
    • 2.4.38 Serametrix
    • 2.4.39 Siemens Healthineers
    • 2.4.40 Sigma Aldrich (now Millipore Sigma)
    • 2.4.41 Tecan
    • 2.4.42 Thermo Fisher Scientific Inc.
    • 2.4.43 TOSOH Bioscience
    • 2.4.44 Wako Diagnostics

3. Market Trends

  • 3.1 Factors Driving Growth
    • 3.1.1 Diagnostic Factors
    • 3.1.2 Changing Technologies Spur Early Instrument Retirement.
    • 3.1.3 Consumer Channels Open Wider.
    • 3.1.4 Immunity Technology Comes of Age
  • 3.2 Factors Limiting Growth
    • 3.2.1 Increased Competition Lowers Price
    • 3.2.2 Threat from PCR Based Instruments.
    • 3.2.3 Lower Barriers to Entry.
    • 3.2.4 Wellness has a downside
  • 3.3 Immunoassay Instrumentation
    • 3.3.1 Instrumentation Tenacity
    • 3.3.2 Declining Cost of Instruments Changes Industry Structure.
    • 3.3.3 LISTING of CURRENT INSTRUMENT SPECIFICATIONS.
    • 3.3.4 Immunoassay - CRISPR Diagnostics.

4. Immunoassay Recent Developments

  • 4.1 Recent Developments - Importance and How to Use This Section
    • 4.1.1 Importance of These Developments
    • 4.1.2 How to Use This Section
  • 4.2 Russian Researchers Develop Rapid Test for Heart Attack
  • 4.3 Quidel Full-Year 2017 Revenues Spike on Triage Acquisition
  • 4.4 Bruker Announces Acquisition of Field-Portable Platform
  • 4.5 Beckman Coulter Goes to Court to Sell its BNP Assay
  • 4.6 DiaSorin to buy Siemens' ELISA Immunodiagnostics Business
  • 4.8 Erba Dx Acquires Calbiotech
  • 4.9 Quidel Closes $14M Acquisition of POC Eye Health Businesses
  • 4.10 Precision for Medicine Buys Immune Monitoring Lab Epiontis
  • 4.11 Immunalysis Receives FDA Clearance for SEFRIA™ Fentanyl Urine Drug Screening Test119
  • 4.12 Zimmer buys CD Diagnostics to gain musculoskeletal Dx
  • 4.14 Abcam, Molecular Devices join forces to develop immunoassays
  • 4.15 Qiagen inks $191M deal to buy infection test panel firm STAT-Dx
  • 4.16 Roche pens septic shock diagnostic pact
  • 4.17 Mologic grabs CE mark for POC vaginosis test
  • 4.18 Over-the-counter HIV test earns CE mark
  • 4.19 Beckman Coulter receives clearance for AMH Immunoassay
  • 4.20 Abbott receives clearance for Next-gen Diagnostic Systems
  • 4.22 Beckman Coulter - Enhancements of Access 2 IA System
  • 4.23 New handheld spectral analyzer uses power of smartphone to detect disease
  • 4.24 Quanterix to Launch High-Sensitivity Benchtop Multiplex Instrument

5. The Global Market

  • 5.1 Global Market by Country

6. Global Market by Application

  • 6.1 Global Market by Application
  • 6.2 Endocrinology Applications
  • 6.3 Immune Applications
  • 6.4 Oncology Applications
  • 6.5 Infectious Disease Applications
  • 6.5 Cardiology Applications
  • 6.6 Other Applications

7. Immunoassay by Technology

  • 7.1 Global Market by Technology
  • 7.2 Enzyme
  • 7.3 Flourescence
  • 7.4 Chemiluminesence
  • 7.5 Nucleic Acid
  • 7.6 Rapid/POC
  • 7.7 Radioimmunoassay and Other

8. Vision of the Future of Immunoassay

Appendices

  • I. United States Medicare System: January 2018 laboratory Fees Schedule - National Limit and Midpoint
Back to Top
전화 문의
F A Q